Fernando Miranda, MD
Medical Oncologist
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
St Francis Medical Center
Residency
College of Georgia
Fellowship
Vanderbilt University ,
Fellowship
American Board of Internal Medicine
TN State Medical License Active through 2017
A Phase I trial of protracted oral fixed-dose temozolomide.
Jones, S.F., Greco, F.A., Gian, V.G., Miranda, F.T., Raefsky, E.L., Hainsworth, J.D., Willcutt, N.T., Beschorner, A.F., Kennerly, G., Burris, H.A.; Cancer. 2005 Nov 1.
See more >>Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
Jones, S.F., Burris, H.A., Hainsworth, J.D., Yardley, D.A., Raefsky, E.A., Miranda, F.T., Kuzur, M.E., Willcutt, N.T., White, M.B., Greco, F.A.; Oncology (Williston Park). 2003 May.
See more >>Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Jones, S.F., Gian, V.G., Greco, F.A., Miranda, F.T., Shipley, D.L., Thompson, D.S., Hainsworth, J.D., Toomey, M.A., Willcutt, N.T., Burris, H.A.; Oncology (Williston Park). 2003 May.
See more >>